Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.44 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.43 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.43 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.43 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.43 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.40 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.39 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.39 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.38 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.38 |
| ▸ | BID | P55957 | 3/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.37 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.37 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.37 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6763527 | 0.98 | ALOX5 (0.47) | ALOX5PTGS2PPARAPTGER4PTGER3 | |
| SCHEMBL16959188 | 0.87 | SCN8A (0.39) | ALOX5PTGS2PTGER4PTGER3PTGER2 | |
| SCHEMBL16829571 | 0.87 | ALOX5 (0.53) | ALOX5PTGS2PPARALIPGBID | |
| SCHEMBL20534823 | 0.85 | LIPG (0.42) | ALOX5PTGS2PPARAPTGER4PTGER3 | |
| SCHEMBL6304044 | 0.82 | LIPG (0.43) | ALOX5PTGS2PPARAPTGER4PTGER3 | |
| SCHEMBL23964582 | 0.82 | PTGER4 (0.43) | ALOX5PTGS2PPARAPTGER4PTGER3 | |
| SCHEMBL11100289 | 0.82 | PTGER4 (0.40) | ALOX5PTGS2PTGER4PTGER3PTGER2 | |
| SCHEMBL27456561 | 0.81 | PTPN1 (0.47) | ALOX5PTGS2PPARAPTGER4PTGER3 | |
| SCHEMBL16791967 | 0.81 | PTGER4 (0.42) | ALOX5PTGS2PPARAPTGER4PTGER3 | |
| SCHEMBL19451864 | 0.80 | PTGER4 (0.58) | PPARAPTGER4PTGER3PTGER2PTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2185125-B1 | COSMETIC EMULSIFIER COMBINATION | BEIERSDORF AG (DE) | 2018-02-21 | — | — | EP | claimed |
| US-20230121157-A1 | ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES | BASF SE (DE) | 2023-04-20 | — | — | US | disclosed |
| US-20140140940-A1 | Cosmetic And Dermatological Photoprotective Preparation With Improved Water Resistance | BEIERSDORF AG (DE) | 2014-05-22 | — | — | US | disclosed |
| US-20100189755-A1 | Dryer Sheets and a Method for Treating Skin | COGNIS IP MANAGEMENT GMBH (DE) | 2010-07-29 | — | — | US | disclosed |
| EP-1640042-B1 | Cosmetic skin-whitening and cleansing composition comprising extracts from lotus, kiwi, orchids and liquorice | COTY PRESTIGE LANCASTER GROUP (DE) | 2009-12-30 | — | — | EP | disclosed |
| EP-1746972-A1 | COSMETIC METHOD FOR TREATING SKIN WITH SUN PRODUCTS AND SUN PRODUCT COMBINATION | Coty B.V. (NL) | 2007-01-31 | — | — | EP | disclosed |
| EP-1640042-A1 | Cosmetic skin-whitening and cleansing composition comprising extracts from lotus, kiwi, orchids and liquorice | Lancaster Group GmbH (DE) | 2006-03-29 | — | — | EP | disclosed |
| WO-2005102260-A1 | COSMETIC METHOD FOR TREATING SKIN WITH SUN PRODUCTS AND SUN PRODUCT COMBINATION | COTY B.V. (NL) | 2005-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230121157-A1 | ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES | CUTA, GLA, DPY30 | ALOX5 172/4885PTGS2 2745/4885PPARA 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.